BRPI0912663A2 - composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival - Google Patents

composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival

Info

Publication number
BRPI0912663A2
BRPI0912663A2 BRPI0912663A BRPI0912663A BRPI0912663A2 BR PI0912663 A2 BRPI0912663 A2 BR PI0912663A2 BR PI0912663 A BRPI0912663 A BR PI0912663A BR PI0912663 A BRPI0912663 A BR PI0912663A BR PI0912663 A2 BRPI0912663 A2 BR PI0912663A2
Authority
BR
Brazil
Prior art keywords
corneal
treatment
pharmaceutical composition
dry eye
conjunctival injury
Prior art date
Application number
BRPI0912663A
Other languages
English (en)
Inventor
Nakayuki Kishimoto
Naoko Shima
Reiko Tabuchi
Yukihiko Mashima
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of BRPI0912663A2 publication Critical patent/BRPI0912663A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0912663A 2008-05-15 2009-05-15 composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival BRPI0912663A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008128418 2008-05-15
PCT/JP2009/059052 WO2009139464A1 (ja) 2008-05-15 2009-05-15 ドライアイおよび／または角結膜障害処置のための医薬組成物

Publications (1)

Publication Number Publication Date
BRPI0912663A2 true BRPI0912663A2 (pt) 2016-01-26

Family

ID=41318823

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912663A BRPI0912663A2 (pt) 2008-05-15 2009-05-15 composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival

Country Status (13)

Country Link
US (1) US20110065642A1 (pt)
EP (1) EP2301561A4 (pt)
JP (3) JP2009298783A (pt)
KR (1) KR20110020819A (pt)
CN (1) CN102026648A (pt)
AU (1) AU2009247173B2 (pt)
BR (1) BRPI0912663A2 (pt)
CA (1) CA2724052A1 (pt)
MX (1) MX2010012416A (pt)
NZ (1) NZ602479A (pt)
RU (2) RU2010151453A (pt)
TW (1) TW201000135A (pt)
WO (1) WO2009139464A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010151453A (ru) * 2008-05-15 2012-06-20 Р-Тек Уено, Лтд. (Jp) Фармацевтическая композиция для лечения сухости глаз и/или повреждения конъюнктивы и роговицы
US9931199B2 (en) * 2014-05-05 2018-04-03 Roberto Gustavo ALBERTAZZI Methods and apparatus for treating keratoconus
EP3288458B8 (en) * 2015-05-01 2019-12-18 DiagnosTear, Ltd. Method for measuring tear constitutents in a tear sample
EP3871682A1 (en) * 2016-10-14 2021-09-01 i.com Medical GmbH Method for establishing, restoring, and preserving homeostasis of the ocular surface
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
JP2021532121A (ja) 2018-07-27 2021-11-25 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド 眼を治療するための組成物及び方法
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (en) 1981-11-12 1984-08-08 The Upjohn Company Albumin-based nucleotides, their replication and use, and plasmids for use therein
EP0091527A3 (en) 1981-12-14 1984-07-25 The President And Fellows Of Harvard College Dna sequences, recombinant dna molecules and processes for producing human serum albumin-like polypeptides
US7198919B1 (en) * 1983-04-25 2007-04-03 Genentech, Inc. Use of alpha factor sequences in yeast expression systems
NZ207926A (en) 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
JPS6041487A (ja) 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
JPS6229985A (ja) 1985-06-17 1987-02-07 ジエネツクス・コ−ポレ−シヨン クロ−ン化プレプロ−ヒト血清アルブミン遺伝子およびヒト血清アルブミン遺伝子、それらの遺伝子を含むプラスミド、プラスミドにより形質転換された微生物、およびその微生物を用いたプレプロ−ヒト血清アルブミン遺伝子の製造方法
JPS6225133A (ja) 1985-07-25 1987-02-03 Matsushita Electric Works Ltd 付加型イミド樹脂プリプレグの製法
FI870103A7 (fi) 1986-01-13 1987-08-01 Genex Corp Ihmisen seerumin albumiinin tuottaminen Bacillus-kannassa.
GB8613388D0 (en) 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
US4723944A (en) 1986-06-05 1988-02-09 Jensen Ole R Fluid collection receptacle with improved non-return valve
JPH0198486A (ja) 1986-06-17 1989-04-17 Genex Corp クロ−ン化プレプロ−ヒト血清アルブミン遺伝子およびヒト血清アルブミン遺伝子、それらの遺伝子を含むプラスミド、プラスミドにより形質転換された微生物、およびその微生物を用いたプレプロ−ヒト血清アルブミンの製造方法
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えｄｎａ、形質転換体
JPH01240191A (ja) * 1988-02-16 1989-09-25 Green Cross Corp:The 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
JPH01219561A (ja) 1988-02-26 1989-09-01 Terumo Corp 栓体およびそれを備えた試料採取用管体
IL89992A0 (en) 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
CA2017176A1 (en) 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
JPH0669365B2 (ja) * 1989-05-22 1994-09-07 株式会社ミドリ十字 アルブミン遺伝子を含むプラスミド、形質転換体、形質転換体の製造方法、アルブミンの製造方法
JP2855130B2 (ja) 1989-07-19 1999-02-10 吉富製薬株式会社 異種蛋白発現用融合酵母菌、該菌の製造方法および異種蛋白の製造方法
JPH0363598A (ja) 1989-07-31 1991-03-19 Mitsubishi Cable Ind Ltd 放射線防護衣料
JPH0363599A (ja) 1989-08-02 1991-03-19 Toshiba Corp 放射能汚染機器等解体物の処理方法およびその輸送容器
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JP3230091B2 (ja) 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JPH0671432B2 (ja) 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
CA2063890C (en) * 1991-03-27 2007-03-13 Masami Miura Mutant aox2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
JP2869417B2 (ja) 1992-09-22 1999-03-10 吉富製薬株式会社 遺伝子操作により得られるヒト血清アルブミン
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CA2225398C (en) * 1996-04-19 2008-07-15 R-Tech Ueno, Ltd. Pharmaceutical composition comprising albumin as an active ingredient
JP3903475B2 (ja) 1999-04-30 2007-04-11 ニプロ株式会社 乾性角膜症治療剤
ES2300398T3 (es) * 2001-04-26 2008-06-16 R-Tech Ueno, Ltd. Uso de albumina en combinacion con factores de crecimiento para inhibir la apoptosis.
JP2004002449A (ja) * 2003-07-14 2004-01-08 Mitsubishi Pharma Corp ヒト血清アルブミンおよびその製造方法
RU2010151453A (ru) * 2008-05-15 2012-06-20 Р-Тек Уено, Лтд. (Jp) Фармацевтическая композиция для лечения сухости глаз и/или повреждения конъюнктивы и роговицы

Also Published As

Publication number Publication date
CN102026648A (zh) 2011-04-20
JP2014205705A (ja) 2014-10-30
AU2009247173B2 (en) 2014-04-17
NZ602479A (en) 2013-05-31
MX2010012416A (es) 2010-12-21
US20110065642A1 (en) 2011-03-17
JP2012180372A (ja) 2012-09-20
EP2301561A4 (en) 2012-02-29
RU2015129822A (ru) 2015-11-10
CA2724052A1 (en) 2009-11-19
JP2009298783A (ja) 2009-12-24
JP5627642B2 (ja) 2014-11-19
WO2009139464A1 (ja) 2009-11-19
EP2301561A1 (en) 2011-03-30
KR20110020819A (ko) 2011-03-03
AU2009247173A1 (en) 2009-11-19
RU2010151453A (ru) 2012-06-20
TW201000135A (en) 2010-01-01

Similar Documents

Publication Publication Date Title
BRPI0813553A2 (pt) composições farmacêuticas e métodos para tratamento de distúrbios do olho seco
PT1881823E (pt) Composições e métodos para o tratamento de transtornos oculares
PT2470191E (pt) Métodos e composições para prevenção ou tratamento de doenças oftálmicas
BRPI0912663A2 (pt) composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival
BRPI0919920A2 (pt) compostos para tratamento de doenças e desordens oftálmicas
BRPI0918670A2 (pt) composições e métodos para o tratamento de disordens mediados por ige
BRPI0917440A2 (pt) composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
BRPI0819241A2 (pt) Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas
PT2894165T (pt) Métodos e composições para o tratamento de distúrbios associados ao complemento
SMT201600080B (it) Inibitori di chinasi janus per il trattamento di occhio secco e altre malattie oculari
BRPI0719918A2 (pt) Tratamento para olho seco usando-se testosterona e progestagênio
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
BR112012004154A2 (pt) "derivados de oxazina e seu uso no tratamento de distúrbios neurológicos"
ES2525801T8 (es) Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0909984A2 (pt) "método de tratamento dos olhos para prevenção de presbiopia e/ou começo de glaucoma e dispositivo para realizar tratamento dos olhos para prevenção de presbiopia e/ou começo de glaucoma"
BRPI1007092A2 (pt) "derivados de hidroxamato, uso dos derivados de hidroxamato, composições farmacêuticas, método para prevenção ou tratamento de doença e método de produção de derivados de hidroxamato"
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
BRPI0911083A2 (pt) métodos para o tratamento ou prenvenção de diabetes mullitus e outros desequilíbrios metabólicos
BRPI1008727A2 (pt) derivados de azol substituídos, composição farmacêutica contendo os derivados, e método para o tratamento de doença de parkinson usando os mesmos
BRPI0919231A2 (pt) agonista de receptor de neuropeptídeo-2, composição farmacêutica que o compreende, seu uso e método para o tratamento ou profilaxia de enfermidades
BRPI1010517A2 (pt) métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
BRPI1016257A2 (pt) composições compreendendo finafloxacino e métodos para tratar infecções oftálmicas, ópticas ou nasais

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)